You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glycoprotein VI

Showing 1 - 25 of 714
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Thrombocytopenic Purpura Trial in Cairo (Eltrombopag, conventional)

Completed
  • Idiopathic Thrombocytopenic Purpura
  • Cairo, Egypt
    Ainshams University , Faculty of medicine , Pediatric Hematology
Oct 26, 2021

Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD

Recruiting
  • Mucopolysaccharidosis Disorders
  • +28 more
  • Stem Cell Transplantation
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 1, 2022

Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)

Not yet recruiting
  • Iron Deficiency Anemia
  • Iron-fortified cookies
  • +3 more
  • (no location specified)
Aug 30, 2023

Iron Deficiency Anemia Trial in Nairobi (dietary supplement, biological, other)

Recruiting
  • Iron Deficiency Anemia
  • Iron supplementation
  • +4 more
  • Nairobi, Kenya
    Jomo Kenyatta University Of Agriculture And Technology
Oct 30, 2023

SARS-CoV Infection, Acute Respiratory Distress Syndrome, COVID-19 Trial in Strasbourg (glenzocimab, Placebo)

Completed
  • SARS-CoV Infection
  • +3 more
  • Strasbourg, France
    Hôpital de Hautepierre
Sep 10, 2021

Acute Ischemic Stroke Trial in Bordeau (Intravenous ACT017 1000 mg, Intravenous Placebo)

Completed
  • Acute Ischemic Stroke
  • Intravenous ACT017 1000 mg
  • Intravenous Placebo
  • Bordeau, France
    Centre Hospitalier Universitaire de Bordeaux,
Oct 5, 2021

Acute Ischemic Stroke Trial in Bordeau (Intravenous glenzocimab (ACT017) 1000 mg, Intravenous Placebo)

Recruiting
  • Acute Ischemic Stroke
  • Intravenous glenzocimab (ACT017) 1000 mg
  • Intravenous Placebo
  • Houston, Texas
  • +1 more
Sep 28, 2022

Stroke, Acute, Stroke, Ischemic Trial (Glenzocimab, Placebo)

Not yet recruiting
  • Stroke, Acute
  • Stroke, Ischemic
  • (no location specified)
Sep 26, 2022

STEMI, Large Thrombus Burden, No-Reflow Phenomenon Trial (Upfront preparation of microcirculation to minimize risks of no-reflow

Not yet recruiting
  • STEMI
  • +2 more
  • Upfront preparation of microcirculation to minimize risks of no-reflow and reperfusion injury
  • (no location specified)
May 26, 2022

Asthma Trial (FF/UMEC/VI, ELLIPTA, FF/VI)

Not yet recruiting
  • Asthma
  • (no location specified)
Feb 24, 2023

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), gp160 MN/LAI-2, ALVAC(1)120(B,MN)GNP (vCP1433))

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • +4 more
  • Birmingham, Alabama
  • +5 more
Oct 27, 2021

Skin Laxity; Facial, Dry Skin; Facial Trial (HydraFacial Syndeo System, ReGen-GF)

Not yet recruiting
  • Skin Laxity; Facial
  • Dry Skin; Facial
  • (no location specified)
Jun 27, 2023

Neurodegenerative Diseases, Alzheimer, Parkinson Disease Trial in Groningen ([18F]MC225)

Recruiting
  • Neurodegenerative Diseases
  • +3 more
  • Groningen, Netherlands
    University Medical Center Groningen
May 9, 2023

Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2 Trial in Durham (No intervention)

Recruiting
  • Glycogen Storage Disease VI
  • +4 more
  • No intervention
  • Durham, North Carolina
    Duke University
Jul 27, 2022

Asthma Trial in China (FF/VI, FF/UMEC/VI, ELLIPTA)

Recruiting
  • Asthma
  • Xiamen, Fujian, China
  • +40 more
Oct 25, 2022

Lip Augmentation, Lip Fullness Trial in Chicago (Volbella or Juvederm Ultra XC filler)

Recruiting
  • Lip Augmentation
  • Lip Fullness
  • Volbella or Juvederm Ultra XC filler
  • Chicago, Illinois
    DeNova Research
Feb 15, 2023

Hiv, HIV, HIV Cardiomyopathy Trial in Denmark (Dolutegravir / Lamivudine Oral Tablet)

Recruiting
  • Hiv
  • +5 more
  • Dolutegravir / Lamivudine Oral Tablet
  • Aalborg, Denmark
  • +4 more
May 26, 2021

Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Rivoceranib Mesylate, Paclitaxel
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jun 7, 2023

Skin Abnormalities Trial (microbotox, fractional carbon dioxide laser)

Not yet recruiting
  • Skin Abnormalities
  • (no location specified)
Jun 19, 2023

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) Trial in Worldwide (Rozanolixizumab, Placebo)

Recruiting
  • Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
  • Scottsdale, Arizona
  • +43 more
Feb 2, 2023

Pterygium Trial in Balikesir (Expression of CD44, E-cadherin and PCNA)

Not yet recruiting
  • Pterygium
  • Expression of CD44, E-cadherin and PCNA
  • Balıkesir, Turkey
    Hümeyra Yildirim
Sep 15, 2023

Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in

Not yet recruiting
  • Cirrhosis
  • +2 more
  • Complete blood count
  • +2 more
  • (no location specified)
Sep 10, 2022

Bilateral Vestibular Loss Trial in Maastricht (Cochlear Vestibular Implant (CVI))

Recruiting
  • Bilateral Vestibular Loss
  • Cochlear Vestibular Implant (CVI)
  • Maastricht, Limburg, Netherlands
    Maastricht UMC+
Dec 5, 2022

Photodamaged Skin Trial (Vitamin C with AHA Exfoliative Serum, Placebo serum)

Not yet recruiting
  • Photodamaged Skin
  • Vitamin C with AHA Exfoliative Serum
  • Placebo serum
  • (no location specified)
Jun 19, 2023

Pediatric Obesity, Childhood Obesity Trial in United States (Placebo, VI-0521 Mid Dose, VI-0521 Top Dose)

Completed
Has Results
  • Pediatric Obesity
  • Childhood Obesity
  • Placebo
  • +2 more
  • Baton Rouge, Louisiana
  • +3 more
Aug 19, 2022